Morphogenesis, Inc. Is Developing a Cell and Gene Therapy Focusing on a Cancer Vaccine Immunotherapy That Uses the Body’s Own Immune System to Kill Solid Tumors
Dr. Patricia Lawman, CEO and co-founder of UF startup Morphogenesis, Inc., a clinical-stage immunotherapy company headquartered in Tampa, talks about the company,... Read More
Morphogenesis, Inc. Moves Forward With Development of Cancer Vaccine
UF startup Morphogenesis, Inc., a clinical-stage immunotherapy company headquartered in Tampa, has been working on the research for nearly 20 years and... Read More
Coolest Office Spaces: Morphogenesis Creates Interactive Spaces for Big Minds
UF startup Morphogenesis is a clinical-stage immunotherapy company headquartered in Tampa. The company’s principal focus is a platform of cancer vaccines that... Read More
Morphogenesis and Lacerta Named as Finalists for SEBIO Awards (SEBIO)
Two UF startups who have incubated at UF Innovate | Sid Martin Biotech have been named as finalists for the SEBIO awards.... Read More
Morphogenesis Focused on Cancer Treatment Launches First Human Clinical Study (Tampa Bay Business Journal)
UF startup Morphogenesis Inc. is launching its first human clinical study for treatment for skin cancer. It’s an important benchmark for the... Read More
Morphogenesis to Begin Clinical Trials on Promising Cancer Therapy (WLRN)
A UF startup based in Tampa has received approval to start clinical trials on a new form of gene therapy to treat... Read More
Morphogenesis, Inc. Raises $16M to Advance into Human Clinical Trials (BioFlorida)
UF startup Morphogenesis, Inc., a Tampa, FL-based immunotherapy company closed a $16 million Series A investment round led by Dr. Kiran Patel... Read More